Adolescent and Young Adult Cancer Survivors
Conditions
Keywords
exercise, physical activity, pilot study, randomized controlled trial, cancer, adolescent and young adult, AYA
Brief summary
More adolescents and young adults are surviving cancer than ever before. Many endure negative effects related to their cancer and its treatment, which reduces their quality of life and functioning. Physical activity is one strategy that has been shown to promote quality of life amongst cancer survivors. However, very little research has focused on adolescent and young adult cancer survivors. Therefore, the purpose of this pilot randomized controlled trial is to explore the feasibility, safety, and potential benefits of a 12-week home-based physical activity intervention in adolescent and young adult cancer survivors.
Interventions
BEHAVIORALPhysical Activity
Participants will receive a 12-week home-based physical activity program that has been individualized using their baseline assessment results. The program will be comprised of aerobic training (2 days/week) and resistance training (2 days/week). The aerobic training will be performed unsupervised. The resistance training will be performed under the supervision of a study team member (who will visit participants homes) for the first 6 weeks to ensure proper form and safety.
Sponsors
University of Ottawa
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
15 Years to 44 Years
Healthy volunteers
No
Inclusion criteria
1. Have been diagnosed with cancer for the first time between the ages of 15 and 39 years; 2. Have completed cancer treatment within 5 years; 3. Currently between the ages of 15 to 44 years; 4. Have no current evidence of progressive disease, secondary cancer (i.e., cancer cells that have spread from the primary cancer), or second cancers (i.e., a new different cancer); 5. Live within 100 km of the University of Ottawa; 6. Be inactive or insufficiently active as determined by a single item screening question (i.e., participants must respond no to the following question: are you currently engaging in moderate physical activity, defined as activity that increases your heart rate and causes you to sweat, on 3 or more days a week?). Screening participants based on their level of physical activity will ensure only those individuals for whom the intervention will have the largest effect are recruited; 7. Able to read, understand, and provide informed consent in English; 8. Ready for physical activity as indicated by answering Physical Activity Readiness Questions (PAR-Q). If participants are not ready for physical activity as determined by the PAR-Q they will need to complete a Physical Activity Readiness Medical Examination Form.
Exclusion criteria
1. Physical impairments precluding participation in physical activity; 2. Unwilling or unable to sign the Participant Informed Consent Form; 3. Received a diagnosis of brain cancer or thyroid cancer. Brain cancer survivors will be excluded as a function of the cognitive impairments associated with their diagnosis and treatment and thyroid cancer survivors will be excluded due to the vastly different treatment regimens. That is, both of these cancers may result in different physical, psychological/emotional, and social effects that could impact the outcomes of interest. Eligible participants who want to participate in the other pre-specified outcome measures to assess cognitive functioning must also meet the following additional inclusion/
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Adherence Rates | Through study completion, an average of 12-24 weeks | The number of physical activity sessions engaged in out of the total recommended as part of the intervention. |
| Retention Rates | Through study completion, an average of 12-24 weeks | The number of participants completing the intervention and all scheduled assessments. |
| Number of Participants with Adverse Events | Through study completion, an average of 12-24 weeks | The number of participants reporting or presenting adverse events (e.g., injury) that occurs as a result of participating in the physical activity intervention and/or its assessments. |
| Recruitment Rates | Through study completion, an average of 12-24 weeks | The number of eligible participants who enrol in the study out of the number who are referred. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Resting Heart Rate | Baseline (week 0), mid-intervention (weeks 6), post-intervention (week 12) | Change in resting heart rate, as measured by a heart rate monitor (Polar A300), from baseline, to mid-intervention, to post-intervention. |
| Blood Pressure | Baseline (week 0), mid-intervention (weeks 6), post-intervention (week 12) | Change in resting blood pressure, using a blood pressure monitor (HealthSmart Digital Blood Pressure Monitor), from baseline, to mid-intervention, to post-intervention. |
| Body Composition: Body Mass Index | Baseline (week 0), mid-intervention (weeks 6), post-intervention (week 12) | Change in body mass as determined by a Tanita scale (TBF-310 GS) that uses bioelectrical impedance to assess body composition from baseline, to mid-intervention, to post-intervention. |
| Aerobic Capacity: 6-Minute Walk Test (CSEP, 2013; Irwin, 2012) | Baseline (week 0), mid-intervention (weeks 6), post-intervention (week 12) | Change in aerobic capacity (i.e., total distance walked in 6 minutes) from baseline, to mid-intervention, to post-intervention. |
| Musculoskeletal Strength: Combined Grip Strength using a Handheld Dynamometer (CSEP, 2013; Irwin, 2012) | Baseline (week 0), mid-intervention (weeks 6), post-intervention (week 12) | Change in musculoskeletal strength (i.e., force exerted in kilograms on the handheld dynamometer) from baseline, to mid-intervention, to post-intervention. |
| Self-Efficacy: Single-Item Version of the Exercise Self-Efficacy Scale (McAuley, 1993) | Baseline (week 0), mid-intervention (weeks 6), post-intervention (week 12) | Change in participants self-reported self-efficacy from baseline, to mid-intervention, to post-intervention. |
| Physical Competence and Physical Self-Esteem: Physical Self-Description Questionnaire Short-Form Appearance, Strength, Endurance, Body Fat, and Physical Self-Esteem scales (Marsh, Martin, & Jackson, 2010) | Baseline (week 0), mid-intervention (weeks 6), post-intervention (week 12) | Change in participants self-reported physical competence and physical self-esteem from baseline, to mid-intervention, to post-intervention. |
| Global Self-Esteem: Rosenberg Global Self-Esteem Scale (Rosenberg, 1965) | Baseline (week 0), mid-intervention (weeks 6), post-intervention (week 12) | Change in participants self-reported global self-esteem from baseline, to mid-intervention, to post-intervention. |
| Body Image: Multidimensional Body-Self Relations Questionnaire Appearance Evaluation and Body Areas Satisfaction scales (Cash, 2000) | Baseline (week 0), mid-intervention (weeks 6), post-intervention (week 12) | Change in participants self-reported body image from baseline, to mid-intervention, to post-intervention. |
| Posttraumatic Growth: Posttraumatic Growth Inventory (Tedeschi & Calhoun, 1996) | Baseline (week 0), mid-intervention (weeks 6), post-intervention (week 12) | Change in participants self-reported posttraumatic growth from baseline, to mid-intervention, to post-intervention. |
| Quality of Life: Medical Outcomes Study 36-Item Short-Form Health Survey (Ware & Sherbourne, 1992) | Baseline (week 0), mid-intervention (weeks 6), post-intervention (week 12) | Change in participants self-reported quality of life from baseline, to mid-intervention, to post-intervention. |
| Participants Experiences: Qualitative Interviews | Baseline (week 0), post-intervention (week 12) | Participants experiences in the intervention (i.e., with physical activity if in the experimental arm or with engaging in their usual lifestyle if in the wait-list control arm) and subsequent changes, if any, in behavioural, physical, psychological, and quality of life outcomes as explored via qualitative interviews (following an interview schedule containing a series of open-ended questions and probes) from baseline to post-intervention. |
| Muscular Endurance: 30-Second Sit to Stand Test (Rikli & Jones, 2001) | Baseline (week 0), mid-intervention (weeks 6), post-intervention (week 12) | Change in muscular endurance (i.e., number of times participants can stand from a seated position in 30 seconds) from baseline, to mid-intervention, to post-intervention. |
| Physical Activity Behaviour: Daily Physical Activity Logbook | Through study completion, an average of 12-24 weeks | Change in daily self-reported daily physical activity from baseline, to mid-intervention, to post-intervention, to follow-up (if applicable; i.e., if participant consents and is eligible to participate in the additional assessments testing cognitive functioning). |
| Physical Activity Behaviour: Leisure Time Exercise Questionnaire (Godin & Shephard, 1985) | Baseline (week 0), mid-intervention (weeks 6), post-intervention (week 12), follow-up (week 24) | Change in self-reported physical activity (over the past 7 days) from baseline, to mid-intervention, to post-intervention, to follow-up (if applicable; i.e., if participant consents and is eligible to participate in the additional assessments testing cognitive functioning). |
| Physical Activity Behaviour: 7-Day Accelerometer Wear (Objective Physical Activity Behaviour) | Baseline (week 0), mid-intervention (weeks 6), post-intervention (week 12), follow-up (week 24) | Change in objective levels of physical activity as measured by accelerometers (Actigraph wGT3XP-BT), which will be worn for a 7 day period from baseline, to mid-intervention, to post-intervention, to follow-up (if applicable; i.e., if participant consents and is eligible to participate in the additional assessments testing cognitive functioning). |
Other
| Measure | Time frame | Description |
|---|---|---|
| Cognitive Functioning: Single Open-Ended Question | Baseline (week 0), post-intervention (week 12), follow-up (week 24) | Change in participants responses to a single open-ended question: Do you ever feel like you have a hard time thinking and/or remembering? from baseline, to post-intervention, to follow-up. NOTE: Once recruited to the main trial, participants will have the option to participate in additional assessments testing cognitive functioning. If interested, participants must meet additional inclusion/exclusion criteria for the additional assessments. |
| Socio-Demographic and Medical Information Questionnaire | Baseline (week 0) | The socio-demographic and medical information collected will be used to describe the sample. |
| Cognitive Functioning: Magnetic Resonance Imaging (MRI) Scans | Baseline (week 0), post-intervention (week 12), follow-up (week 24) | Change in participants cognitive functioning, as assessed by a structural scan, a resting state functional MRI (fMRI) procedure, four fMRI tasks, and a diffusion tensor imaging sequence (lasting approximately 60 minutes), from baseline, to post-intervention, to follow-up. NOTE: Once recruited to the main trial, participants will have the option to participate in additional assessments testing cognitive functioning. If interested, participants must meet additional inclusion/exclusion criteria for the additional assessments. |
Countries
Canada
Outcome results
None listed